The Clinical Manifestations and Efficacy of Different Treatments Used for Nephrogenic Systemic Fibrosis: A Systematic Review [0.03%]
肾源性系统纤维化的临床表现及不同治疗方法的疗效：系统回顾
Shaheer Farooqi,Afshan Mumtaz,Aabiya Arif et al.
Shaheer Farooqi et al.
Aim: Nephrogenic systemic fibrosis (NSF) is a rare disorder that occurs in association majorly with chronic kidney disease (CKD). The lack of collective quantitative data on its clinical manifestations and the different t...
Genetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management [0.03%]
慢性肾病的遗传易感性：联系、风险和管理
Hanny Sawaf,Tariku T Gudura,Sylvester Dorobisz et al.
Hanny Sawaf et al.
Chronic kidney disease (CKD) is associated with significant morbidity and mortality worldwide. In recent years, our understanding of genetic causes of CKD has expanded significantly with several renal conditions having been identified. This...
Lung Ultrasound Estimates the Overhydration and Benefits Blood Pressure Control in Normal or Mild Symptomatic Hemodialysis Patients [0.03%]
肺超声评估过度水化及对血液透析患者的血压控制的益处
Akeatit Trirattanapikul,Sawinee Kongpetch,Eakalak Lukkanalikitkul et al.
Akeatit Trirattanapikul et al.
Introduction: Lung ultrasound (LUS) is used for dry weight guidance by assessment of pulmonary congestion in hemodialysis (HD) patients. The aim of this study was to estimate amounts of accumulated fluid by total LUS scor...
Estimates of Chronic Kidney Diseases Associated with Proton-Pump Inhibitors Using a Retrospective Hospital-Based Cohort in Thailand [0.03%]
使用泰国医院的回顾性队列研究质子泵抑制剂与慢性肾脏疾病的关系估算值
Tanavij Pannoi,Chissanupong Promchai,Penjamaporn Apiromruck et al.
Tanavij Pannoi et al.
Purpose: Potential adverse outcomes of Proton pump inhibitors (PPIs) have increasingly been reported. The potential risks to PPIs include hypomagnesemia and chronic kidney disease (CKD). Unlike a real-world electronic med...
Uric Acid, Ferritin, Albumin, Parathyroid Hormone and Gamma-Glutamyl Transferase Concentrations are Associated with Uremic Cardiomyopathy Characteristics in Non-Dialysis and Dialysis Chronic Kidney Disease Patients [0.03%]
尿酸，铁蛋白，白蛋白，甲状旁腺激素和γ-谷氨酰转移酶浓度与非透析及透析慢性肾脏病患者的发生尿毒症心肌病有关
Grace Tade,Hon-Chun Hsu,Angela J Woodiwiss et al.
Grace Tade et al.
Introduction: Circulating uric acid, ferritin, albumin, intact parathyroid hormone and gamma-glutamyl transferase each participate in biochemical reactions that reduce or/and enhance oxidative stress, which is considered ...
Obstacles to Early Diagnosis and Treatment of Pruritus in Patients with Chronic Kidney Disease: Current Perspectives [0.03%]
慢性肾脏病患者瘙痒症早期诊断和治疗的障碍：当前认识
Chandra Mauli Jha,Hormaz Dara Dastoor,Natrajan Gopalakrishnan et al.
Chandra Mauli Jha et al.
Chronic kidney disease-associated pruritus (CKD-aP) is a common condition amongst patients with advanced chronic kidney disease (CKD). Several studies have confirmed that more than four out of ten early-stage CKD patients suffer from this c...
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice [0.03%]
鞘氨醇激酶2抑制剂Opaganib保护小鼠免受急性肾损伤
Lynn W Maines,Cecelia L Green,Staci N Keller et al.
Lynn W Maines et al.
Introduction: Acute kidney injury (AKI) is a common multifactorial adverse effect of surgery, circulatory obstruction, sepsis or drug/toxin exposure that often results in morbidity and mortality. Sphingolipid metabolism i...
Full and Booster Doses of SARS-CoV-2 mRNA-1273 Vaccine Increase Waning Antibody Levels After Completed Vaccination Among Dialysis Patients at a Large Dialysis Organization [0.03%]
大型透析组织中完成疫苗接种后抗体水平下降的透析患者在接受SARS-CoV-2 mRNA-1273疫苗的完全剂量和加强剂量后抗体水平增加
Linda H Ficociello,Joanna Willetts,Claudy Mullon et al.
Linda H Ficociello et al.
Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study [0.03%]
重症Covid-19患者进行两种不同的体外血液净化方式时血浆细胞因子的 kinetics：队列研究
Daniela Ponce,Welder Zamoner,Luis Eduardo Magalhães et al.
Daniela Ponce et al.
Background: In the absence of direct therapy for COVID-19, extracorporeal blood treatment (EBT) could represent an option for cytokine removal. Objective:...
Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives [0.03%]
达格列净在CKD管理中的临床评估：重点关注患者选择和临床展望
Khaled Nashar,Patricia Khalil
Khaled Nashar
Dapagliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that was recently approved in the USA and the EU for the treatment of adults with chronic kidney disease (CKD) with or without diabetes mellitus (DM). The DAPA-CK...